Exploring the Mechanism of Aspirin in the Treatment of Kawasaki Disease Based on Molecular Docking and Molecular Dynamics

Table 1

Molecular docking of aspirin and protein receptor.

	Binding energy (kcal) (mol)	Ligand efficiency	Inhib constant
ELANE	−6.23	−0.48	27.15
NFKBIA	−5.62	−0.43	75.76
IKBKB	−5.05	−0.39	198.29
KDR	−5.25	−0.4	141.49
IL2	−4.44	−0.34	560.86
CASP3	−5.59	−0.43	79.72
FGF1	−5.81	−0.54	7.65
CTSG	−7.17	−0.55	5.55